• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSLYRIC¿; FLOW CYTOMETRIC REAGENTS AND ACCESS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSLYRIC¿; FLOW CYTOMETRIC REAGENTS AND ACCESS Back to Search Results
Catalog Number 663029
Medical Device Problem Code Contamination (1120)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/24/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
D.4.Medical device expiration date: na.H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.E.1.Initial reporter address: (b)(6).
 
Event or Problem Description
It was reported that carryover involving patient samples was observed during use with the bd facslyric¿.The following information was provided by the initial reporter: sample carryover at end of the acquisition.1.Were patient samples contaminated or was there carryover (cross-contamination/mixing) between patient samples? if no, no further questions required.Patient samples contaminated, carryover between patient samples, unknown - go to question #2.Carryover between patient samples.2.Please describe any additional details: go to patient samples checklist.Customer informed they are having sample carryover at end of the acquisition.
 
Event or Problem Description
It was reported that carryover involving patient samples was observed during use with the bd facslyric¿.The following information was provided by the initial reporter: sample carryover at end of the acquisition.1.Were patient samples contaminated or was there carryover (cross-contamination/mixing) between patient samples? if no, no further questions required.Patient samples contaminated, carryover between patient samples, unknown - go to question #2.Carryover between patient samples.2.Please describe any additional details: go to patient samples checklist.Customer informed they are having sample carryover at end of the acquisition.
 
Additional Manufacturer Narrative
The following field has been updated with corrected information: h.6 imdrf annex g: g07001.H.6: investigation summary: based on the investigation results, the reported issue of sample carryover was confirmed.Investigation results that were performed on the indicated failure mode were the following: manufacturing, defect, and complaint trends were reviewed.A return sample was not requested for evaluation as no parts were replaced.Potential cause was due to improper sit flushes between samples, and the issue was resolved after applications provided remote support and instructed the customer to implement additional sit flushes following sample acquisition.Although the instrument was used for diagnostic testing, the issue was resolved before any patient sample results were used for any diagnosis or treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACSLYRIC¿
Common Device Name
FLOW CYTOMETRIC REAGENTS AND ACCESS
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
155 north mccarthy boulevard
milpitas CA 95035
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
155 north mccarthy boulevard
milpitas CA 95035
Manufacturer Contact
fahmy razak - mdr
155 north mccarthy boulevard
milpitas, CA 95035
8772328995
MDR Report Key22396892
Report Number3027394506-2025-00029
Device Sequence Number13500558
Product Code OYE
UDI-Device Identifier00382906630292
UDI-Public(01)00382906630292(11)220813
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K201814
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/09/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number663029
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/27/2025
Supplement Date Received by Manufacturer10/09/2025
Initial Report FDA Received Date07/03/2025
Supplement Report FDA Received Date10/15/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/13/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-